For the year ending 2025-12-31, ATNM has $51,775K in assets. $43,941K in debts. $47,998K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 47,998 | |||
| Prepaid expenses and other current assets | 1,383 | |||
| Total current assets | 49,381 | |||
| Property and equipment, net of accumulated depreciation of 1,064 and 891 | 295 | |||
| Restricted cash long term | 335 | |||
| Operating lease right-of-use assets | 1,754 | |||
| Finance leases right-of-use assets | 10 | |||
| Total assets | 51,775 | |||
| Accounts payable and accrued expenses | 7,247 | |||
| Operating leases current liability | 711 | |||
| Finance leases current liability | 11 | |||
| Total current liabilities | 7,969 | |||
| Long-term license revenue deferred | 35,000 | |||
| Long-term operating lease obligations | 972 | |||
| Total liabilities | 43,941 | |||
| Common stock, 0.001 par value 1,000,000,000 shares authorized 31,195,891 shares issued and outstanding at december 31, 2025 and 2024, respectively | 31 | |||
| Additional paid-in capital | 417,536 | |||
| Accumulated other comprehensive loss | -20 | |||
| Accumulated deficit | -409,713 | |||
| Total stockholders equity | 7,834 | |||
| Total liabilities and stockholders equity | 51,775 | |||
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)